Capitolis Liquid Global Markets LLC purchased a new stake in Amprius Technologies, Inc. (NYSE:AMPX – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 680,600 shares of the company’s stock, valued at approximately $7,160,000.
Several other hedge funds and other institutional investors have also made changes to their positions in AMPX. Bank of America Corp DE boosted its position in shares of Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after purchasing an additional 3,055 shares during the last quarter. Ameritas Investment Partners Inc. increased its holdings in Amprius Technologies by 2,043.2% in the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock valued at $40,000 after purchasing an additional 9,072 shares during the last quarter. Rhumbline Advisers lifted its stake in Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after buying an additional 5,951 shares during the period. Legal & General Group Plc lifted its stake in Amprius Technologies by 1,385.4% in the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after buying an additional 9,684 shares during the period. Finally, XTX Topco Ltd bought a new position in Amprius Technologies during the second quarter worth about $44,000. 5.04% of the stock is currently owned by institutional investors.
Key Headlines Impacting Amprius Technologies
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
- Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
- Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
- Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
- Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)
Amprius Technologies Trading Down 2.0%
Amprius Technologies (NYSE:AMPX – Get Free Report) last released its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.The firm had revenue of $25.23 million during the quarter, compared to analysts’ expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, equities research analysts predict that Amprius Technologies, Inc. will post -0.45 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on AMPX. B. Riley Financial boosted their target price on Amprius Technologies from $16.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, March 9th. Craig Hallum lifted their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Cantor Fitzgerald boosted their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, March 6th. William Blair reaffirmed an “outperform” rating on shares of Amprius Technologies in a research note on Friday, March 6th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $19.75.
View Our Latest Stock Report on Amprius Technologies
Insider Transactions at Amprius Technologies
In other Amprius Technologies news, Director Wen Hsuan Hsieh sold 413,146 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $18.44, for a total value of $7,618,412.24. Following the sale, the director owned 44,444 shares in the company, valued at approximately $819,547.36. The trade was a 90.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CTO Constantin Ionel Stefan sold 492,827 shares of the business’s stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an average price of $12.04, for a total value of $5,933,637.08. Following the completion of the sale, the chief technology officer owned 748,696 shares in the company, valued at $9,014,299.84. The trade was a 39.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 2,929,357 shares of company stock valued at $37,783,110 over the last three months. 12.80% of the stock is currently owned by corporate insiders.
Amprius Technologies Company Profile
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
See Also
- Five stocks we like better than Amprius Technologies
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding AMPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amprius Technologies, Inc. (NYSE:AMPX – Free Report).
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
